Figure 4.
Inhibition of the growth of hematopoietic tumors. Mice (10 mice/group) were treated with qVEGFR (•), mVEGFR (▪), ALUM (▴), or PBS alone (⋄) at day 7 after 5 × 105 MOPC-315 (A,C) or EL4 (B,D) were introduced subcutaneously into mice. Mice were treated as described in the legend to Figure 2. Treatment with qVEGFR resulted in the inhibition of tumor growth and longer life span. Error bars indicate SEM.
